RecruitingNCT03897374

Strategic Targeting for Optimal Prevention of Cancer


Sponsor

ClinLogic LLC

Enrollment

120,000 participants

Start Date

Mar 26, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Genetic Testing for people with early detection of cancer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTGenetic Testing

Buccal swab


Locations(1)

Sunbeam Clinical

Prosper, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03897374


Related Trials